U.S. Companion Animal Arthritis Market Size & Outlook

The companion animal arthritis market in the United States is expected to reach a projected revenue of US$ 1,604.8 million by 2030. A compound annual growth rate of 5.6% is expected of the United States companion animal arthritis market from 2022 to 2030.
Revenue, 2021 (US$M)
$983.1
Forecast, 2030 (US$M)
$1,604.8
CAGR, 2022 - 2030
5.6%
Report Coverage
U.S.

U.S. companion animal arthritis market highlights

  • The U.S. companion animal arthritis market generated a revenue of USD 983.1 million in 2021 and is expected to reach USD 1,604.8 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 5.6% from 2022 to 2030.
  • In terms of segment, dogs was the largest revenue generating animal type in 2021.
  • Cats is the most lucrative animal type segment registering the fastest growth during the forecast period.

Companion animal arthritis market data book summary

Market revenue in 2021USD 983.1 million
Market revenue in 2030USD 1,604.8 million
Growth rate5.6% (CAGR from 2021 to 2030)
Largest segmentDogs
Fastest growing segmentCats
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDogs, Cats, Other Animal Type
Key market players worldwideZoetis, Virbac SA, Elanco Animal Health Inc, Boehringer Ingelheim, CEVA Inc, Dechra Pharmaceuticals, Vetoquinol SA, NextGen Healthcare, K-Laser, Norbrook

Other key industry trends

  • In terms of revenue, U.S. accounted for 33.7% of the global companion animal arthritis market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. companion animal arthritis market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 194.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Companion Animal Arthritis Market Companies

Name Profile # Employees HQ Website

U.S. companion animal arthritis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal arthritis market will help companies and investors design strategic landscapes.


Dogs was the largest segment with a revenue share of 60.54% in 2021. Horizon Databook has segmented the U.S. companion animal arthritis market based on dogs, cats, other animal type covering the revenue growth of each sub-segment from 2018 to 2030.


  • U.S. Companion Animal Arthritis Animal Type Outlook (Revenue, USD Million, 2018-2030)
    • Dogs
    • Cats
    • Other Animal Type
  • U.S. Companion Animal Arthritis Treatment Outlook (Revenue, USD Million, 2018-2030)
    • Medication
      • NSAIDs
      • Monoclonal Antibodies
      • Other Medications
    • Supplements
    • Other Treatments
  • U.S. Companion Animal Arthritis Indication Outlook (Revenue, USD Million, 2018-2030)
    • Osteoarthrtitis
    • Other Arthritis
  • U.S. Companion Animal Arthritis Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Veterinary Hospitals & Clinics
    • Retail Pharmacies
    • Online Sales
    • Others

Reasons to subscribe to U.S. companion animal arthritis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. companion animal arthritis market databook

  • Our clientele includes a mix of companion animal arthritis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. companion animal arthritis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. companion animal arthritis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. companion animal arthritis market size, by animal type, 2018-2030 (US$M)

U.S. Companion Animal Arthritis Market Outlook Share, 2021 & 2030 (US$M)

U.S. companion animal arthritis market size, by animal type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more